# DUSP29

## Overview
DUSP29, or dual specificity phosphatase 29, is a gene that encodes a protein involved in the regulation of key signaling pathways within skeletal muscle cells. The protein, dual specificity phosphatase 29, is categorized as a phosphatase due to its ability to dephosphorylate both serine/threonine and tyrosine residues. It plays a significant role in modulating the MAP kinase signaling pathway by dephosphorylating ERK1/2, which is crucial for cell growth, proliferation, and differentiation (Cooper2020Dualspecificity). Additionally, DUSP29 interacts with AMP-activated protein kinase (AMPK) and the glucocorticoid receptor (GR), influencing energy balance and muscle mass regulation (Cooper2020Dualspecificity). The gene is notably expressed during the late stages of muscle cell differentiation, suggesting its involvement in muscle development and homeostasis (Cooper2020Dualspecificity). DUSP29's regulatory functions have implications for conditions such as muscle atrophy and insulin resistance, highlighting its potential clinical significance (Needham2024Personalized).

## Function
DUSP29 (dual specificity phosphatase 29) is involved in modulating key signaling pathways within skeletal muscle cells. It primarily affects the MAP kinase signaling pathway by dephosphorylating ERK1/2, which plays a crucial role in cell growth, proliferation, and differentiation. Overexpression of DUSP29 leads to a reduction in ERK1/2 phosphorylation, although the protein levels of ERK1/2 remain unchanged, indicating its role in regulating the phosphorylation status rather than the expression of these kinases (Cooper2020Dualspecificity).

DUSP29 also interacts with AMPK, a significant regulator of skeletal muscle mass, by reducing AMPK protein levels without affecting its phosphorylation status. This interaction suggests a role in energy balance and muscle mass regulation (Cooper2020Dualspecificity). Additionally, DUSP29 modulates glucocorticoid receptor (GR) activity. It increases GR protein and phosphorylation levels while attenuating GR's transcriptional activity in response to glucocorticoids, such as dexamethasone, in muscle cells (Cooper2020Dualspecificity).

The gene is highly expressed during late differentiation of muscle cells, indicating its involvement in muscle cell differentiation and development (Cooper2020Dualspecificity). These activities highlight DUSP29's role in maintaining cellular homeostasis and its potential impact on muscle physiology.

## Clinical Significance
DUSP29 has been implicated in various conditions related to skeletal muscle atrophy and insulin resistance. Its expression is significantly upregulated during neurogenic skeletal muscle atrophy, suggesting a role in muscle wasting conditions. Conversely, DUSP29 expression is downregulated in response to dexamethasone treatment, indicating its involvement in glucocorticoid-induced muscle atrophy (Cooper2020Dualspecificity). The gene's expression is also associated with insulin sensitivity, as it is differentially regulated in skeletal muscle insulin resistance, highlighting its potential role in metabolic disorders (Needham2024Personalized).

DUSP29's interaction with signaling pathways, such as the MAP kinase pathway, further underscores its clinical significance. It modulates the ERK1/2 cascade, impacting muscle cell differentiation and potentially contributing to muscle atrophy (Cooper2020Dualspecificity). The gene's ability to attenuate glucocorticoid receptor activity in muscle cells suggests a complex regulatory role that could influence the development of muscle-related diseases (Cooper2020Dualspecificity). These findings indicate that alterations in DUSP29 expression or function may contribute to the pathogenesis of muscle atrophy and metabolic disorders, although further research is needed to fully elucidate its clinical implications.

## Interactions
DUSP29, also known as dual specificity phosphatase 29, is involved in several interactions with key signaling proteins in skeletal muscle cells. It modulates the MAP kinase signaling pathway by affecting ERK1/2 phosphorylation, specifically inhibiting ERK1/2 without altering their protein levels, which suggests an inhibitory interaction (Cooper2020Dualspecificity). Although direct physical interactions between DUSP29 and ERK1/2 or p38 were not observed, the effects are likely mediated through downstream signaling pathways (Cooper2020Dualspecificity).

DUSP29 also interacts with AMP-activated protein kinase (AMPK), a crucial regulator of skeletal muscle mass. It reduces AMPK protein levels in differentiated myotubes, indicating a destabilizing interaction, although the phosphorylation status of AMPK remains unchanged (Cooper2020Dualspecificity).

In relation to glucocorticoid receptor (GR) activity, DUSP29 overexpression attenuates dexamethasone-induced GR activity, suggesting an inhibitory interaction. It also increases GR protein and phosphorylation levels at S229, indicating a complex interaction that may involve both inhibitory and activating elements (Cooper2020Dualspecificity). These interactions highlight DUSP29's role in modulating key signaling pathways in muscle cells.


## References


1. (Needham2024Personalized) Personalized phosphoproteomics of skeletal muscle insulin resistance and exercise links MINDY1 to insulin action. This article has 1 citations.

[2. (Cooper2020Dualspecificity) Lisa M. Cooper, Rita C. West, Caleb S. Hayes, and David S. Waddell. Dual-specificity phosphatase 29 is induced during neurogenic skeletal muscle atrophy and attenuates glucocorticoid receptor activity in muscle cell culture. American Journal of Physiology-Cell Physiology, 319(2):C441â€“C454, August 2020. URL: http://dx.doi.org/10.1152/ajpcell.00200.2020, doi:10.1152/ajpcell.00200.2020. This article has 6 citations.](https://doi.org/10.1152/ajpcell.00200.2020)